Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FCYNB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,948
Award facts
- Contract value 100% obligated
- $39,947.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $39,947.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-competitive delivery order, issued without a set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as a child contract under its larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle valued through December 2026.
This delivery order supports the Department of Defense's military healthcare supply chain through AmerisourceBergen's established role as a pharmaceutical prime vendor. RINVOQ (upadacitinib) is a prescription medication used in the treatment of inflammatory conditions, reflecting the company's ongoing provision of specialty pharmaceuticals and brand-name medications to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The award demonstrates AmerisourceBergen's continued capability to meet competitive federal procurement requirements across a diverse portfolio of medical products and therapeutic domains within the military healthcare system.
Quick answers
Who was awarded contract SPE2DB25FCYNB?
SPE2DB25FCYNB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FCYNB worth?
The government has obligated $39,948 on SPE2DB25FCYNB.
Is contract SPE2DB25FCYNB an order under another contract?
Yes. SPE2DB25FCYNB is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FCYNB competed?
The extent of competition for SPE2DB25FCYNB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award